Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts

Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

  • Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
  • Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis
  • Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors
  • Insights into tertiary lymphoid structures in the solid tumor microenvironment
  • Tumorigenic bacteria in colorectal cancer mechanisms and treatments
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Articles

  • You have access
    Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
    Duo Zuo, Yongzi Chen, Xinwei Zhang, Zhuozhi Wang, Wenna Jiang, Fan Tang, Runfen Cheng, Yi Sun, Lu Sun, Li Ren and Rui Liu
    Cancer Biology & Medicine July 2022, 19 (7) 1029-1046; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0516
  • You have access
    Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors
    Yangling Li, Dongmei Zhou, Shuang Xu, Mingjun Rao, Zuoyan Zhang, Linwen Wu, Chong Zhang and Nengming Lin
    Cancer Biology & Medicine July 2022, 19 (7) 1109-1110; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0172
  • You have access
    Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
    Leyi Yao, Qian Zhao, Ding Yan, Ziying Lei, Yali Hao, Jinghong Chen, Qian Xue, Xiaofen Li, Qingtian Huang, Daolin Tang, Q. Ping Dou, Xin Chen and Jinbao Liu
    Cancer Biology & Medicine July 2022, 19 (7) 1061-1077; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0598
  • You have access
    Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
    Wuyin Wang, Lu Zhang and Zhijun Sun
    Cancer Biology & Medicine July 2022, 19 (7) 948-964; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0049
  • You have access
    SY-1530, a highly selective BTK inhibitor, effectively treats B-cell malignancies by blocking B-cell activation
    Liao Wang, Yinghui Sun, Xijie Liu, Hongjuan Li, Chang Lu, Ronghui Yang, Chuanzhen Yang and Binghui Li
    Cancer Biology & Medicine July 2022, 19 (7) 995-1007; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0291
  • You have access
    Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial
    Jingjing Wu, Fenghua Gao, Wenhua Wang, Xudong Zhang, Meng Dong, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Linan Zhu, Mengjie Ding, Songtao Niu, Zhaoming Li, Yu Chang, Feifei Nan, Jiaqian Yan, Hui Yu, Xiaolong Wu, Zhiyuan Zhou, Jieming Zhang and Mingzhi Zhang
    Cancer Biology & Medicine July 2022, 19 (7) 1089-1099; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0026
View more latest articles

Current issue

Cancer Biology & Medicine: 19 (7)
Cancer Biology & Medicine
Vol. 19, Issue 7
15 Jul 2022
  • Table of Contents
  • Index by author

Submit

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
Back to top

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2022 Cancer Biology & Medicine

Powered by HighWire